Cargando…

Cluster analysis of kidney function decline among males with Fabry disease in a large United States electronic health records database

BACKGROUND: Fabry disease (FD) is an X-linked lysosomal storage disorder caused by deficient α-galactosidase A activity. The spectrum of disease includes phenotypes ranging from “classic” to “later-onset,” with varying kidney disease progression. Identifying patterns of declining kidney function and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiorean, Alexandra, Lyn, Nicole, Kabadi, Shaum, Blanchon, Margot, Hayat, Paul, Loustalot, Paul, Maski, Manish, Montmerle, Martin, Ponce, Elvira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539200/ https://www.ncbi.nlm.nih.gov/pubmed/37061786 http://dx.doi.org/10.1093/ndt/gfad071

Ejemplares similares

Development of an algorithm for finding pertussis episodes in a population-based electronic health record database
por: Daluwatte, Chathuri, et al.
Publicado: (2023)

Development of a rare disease algorithm to identify persons at risk of Gaucher disease using electronic health records in the United States
por: Wilson, Amanda, et al.
Publicado: (2023)

Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysis
por: Ortiz, Alberto, et al.
Publicado: (2020)

Joint Effects of Obesity and Vitamin D Insufficiency on Insulin Resistance and Type 2 Diabetes: Results from the NHANES 2001–2006
por: Kabadi, Shaum M., et al.
Publicado: (2012)

Stratification of patients with unclassified pain in the FabryScan database
por: Forstenpointner, Julia, et al.
Publicado: (2019)

Utilization of Positive and Negative Controls to Examine Comorbid Associations in Observational Database Studies
por: Desai, Jigar R., et al.
Publicado: (2017)

Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

Multivariate Path Analysis of Serum 25-Hydroxyvitamin D Concentration, Inflammation, and Risk of Type 2 Diabetes Mellitus
por: Kabadi, Shaum M., et al.
Publicado: (2013)

Epidemiologic patterns of biliary tract cancer in the United States: 2001–2015
por: Koshiol, Jill, et al.
Publicado: (2022)

Improvement of gastrointestinal symptoms in a significant proportion of male patients with classic Fabry disease treated with agalsidase beta: A Fabry Registry analysis stratified by phenotype
por: Hopkin, Robert J., et al.
Publicado: (2020)

Development of the Fabry Disease Patient-Reported Outcome (FD-PRO): a new instrument to measure the symptoms and impacts of Fabry Disease
por: Hamed, Alaa, et al.
Publicado: (2021)

Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

Estimating the pertussis burden in adolescents and adults in the United States between 2007 and 2019
por: Macina, Denis, et al.
Publicado: (2023)

Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States
por: St. Peter, Wendy L., et al.
Publicado: (2018)

Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees
por: Patel, Krish, et al.
Publicado: (2019)

Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry disease
por: Hamed, Alaa, et al.
Publicado: (2021)

Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis
por: Epperla, Narendranath, et al.
Publicado: (2020)

Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population
por: Goyal, Ravi K., et al.
Publicado: (2021)

Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease
por: Mauhin, Wladimir, et al.
Publicado: (2020)

First 2 Fabry Cases with Novel Mutation and Their Associated Clusters in Malaysia
por: Tang, Andy Sing Ong, et al.
Publicado: (2021)

Treatment profile and complications associated with cryotherapy for localized prostate cancer: A population-based study
por: Roberts, Calpurnyia B., et al.
Publicado: (2011)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Fabry disease
por: Germain, Dominique P
Publicado: (2010)

Fabry Cardiomyopathy
por: Yoon, Jae Yong, et al.
Publicado: (2013)

A “cluster” of ten uterine anomalies observed in a single center over a short period of 4 weeks: a case series
por: Kabadi, Yogindrakumar M., et al.
Publicado: (2022)

19th Texas Symposium on Relativistic Astrophysics and Cosmology : Texas in Paris
por: Aubourg, E, et al.
Publicado: (2000)

Fabry-Perot interferometers
por: Mora-Hernandez, G
Publicado: (1988)

Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney
por: D’Elia, John A, et al.
Publicado: (2009)

Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Patients with Obstructive Sleep Apnea
por: Maski, Manish R., et al.
Publicado: (2016)

Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
por: Cammisa, Marco, et al.
Publicado: (2013)

Frequency of Fabry disease in male and female haemodialysis patients in Spain
por: Gaspar, Paulo, et al.
Publicado: (2010)

Monitoring globotriaosylsphingosine in a Korean male patient with Fabry disease
por: Jang, Heejoon, et al.
Publicado: (2019)

Semen and male genital tract characteristics of patients with Fabry disease: the FERTIFABRY multicentre observational study
por: Papaxanthos-Roche, Aline, et al.
Publicado: (2019)

Fabry nephropathy: a review – how can we optimize the management of Fabry nephropathy?
por: Waldek, Stephen, et al.
Publicado: (2014)

Cornea verticillata caused by Fabry diseaseCórnea verticilata por doença de Fabry
por: Costa, Ana Luiza Fontes de Azevedo, et al.
Publicado: (2014)

Bridging the Gap Between Vessels and Nerves in Fabry Disease
por: Forstenpointner, Julia, et al.
Publicado: (2020)

Severe manifestations and treatment of COVID-19 in a transplanted patient with Fabry disease
por: Mahoney, Ryan, et al.
Publicado: (2021)

Prevalence of Fabry disease in male dialysis patients: Argentinean screening study
por: Frabasil, Joaquín, et al.
Publicado: (2019)

Fabry Disease and Early Stroke
por: Feldt-Rasmussen, U.
Publicado: (2011)

A Case of Fabry Cardiomyopathy
por: Nah, Jong Chun, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_lnltq59o5jd82qbkocdnvf0bnj